Nasal spray compositions

An aqueous, topical, nasal decongestant composition comprising an amount of oxymetazoline or a pharmaceutically acceptable salt thereof sufficient to effect nasal decongestion and an aqueous carrier comprising:

• 70 to 90% by weight/volume of water;
• 0.10 to 5.00% by weight/volume of an aromatic alcohol;
• 0.01 to 0.3% by weight/volume of a non-mercurial antimicrobial preservative;
• 0 to 10% by weight/volume of a moisturizing agent;
• 0 to 0.10% by weight/volume of an antioxidant;
• 0 to 2.00% by weight/volume of a surfactant;
• 0 to 0.75% by weight/volume of menthol;
• 0 to 0.15% by weight/volume of camphor;
• 0 to 0.15% by weight/volume of eucalyptol;
• a sufficient amount of a pharmaceutically acceptable buffer to maintain the pH of the composition within the range of about 4.00 to 8.00;
• and
• QS water,
• said composition being free of mercurial antimicrobial preservatives.